COFCO Biotechnology Co., Ltd.

XSEC:000930 Stock Report

Market Cap: CN¥10.8b

COFCO Biotechnology Future Growth

Future criteria checks 3/6

COFCO Biotechnology is forecast to grow earnings and revenue by 104.1% and 1.8% per annum respectively. EPS is expected to grow by 105.2% per annum. Return on equity is forecast to be 5.7% in 3 years.

Key information

104.1%

Earnings growth rate

105.2%

EPS growth rate

Chemicals earnings growth39.6%
Revenue growth rate1.8%
Future return on equity5.7%
Analyst coverage

Low

Last updated30 Apr 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSEC:000930 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202621,543705N/A1,4541
12/31/202520,659488N/A9271
12/31/202420,40481N/A2911
9/30/202420,782-259335791N/A
6/30/202420,980-2051,5642,054N/A
3/31/202420,588-5782,6903,225N/A
12/31/202320,379-6021,3231,958N/A
9/30/202319,743-240-347335N/A
6/30/202318,619-63-1,016-391N/A
3/31/202319,060711-2,498-1,909N/A
1/1/202319,9181,059143708N/A
9/30/202220,3701,1604801,235N/A
6/30/202222,1421,2151,8402,712N/A
3/31/202223,3201,1233,1864,259N/A
1/1/202223,5601,1303,7324,842N/A
9/30/202124,0119941,1882,354N/A
6/30/202122,630928-1,665-555N/A
3/31/202121,460848-2,466-1,434N/A
12/31/202019,909593-3,898-2,911N/A
9/30/202019,569737-1,061-180N/A
6/30/202019,8837729301,843N/A
3/31/202018,9356361,2972,171N/A
12/31/201919,4725932,7493,650N/A
9/30/201918,4243322,4563,289N/A
6/30/201917,72030413865N/A
3/31/201917,850430-1,111-246N/A
12/31/201817,704483-1,792-923N/A
9/30/201824,4801,254-499894N/A
6/30/201821,8481,070N/A1,483N/A
3/31/201818,821967N/A1,647N/A
12/31/201715,892929N/A2,017N/A
9/30/20176,164237N/A1,239N/A
6/30/20175,898339N/A1,022N/A
3/31/20175,854232N/A888N/A
12/31/20165,603127N/A785N/A
9/30/20165,446-801N/A441N/A
6/30/20165,593-1,083N/A533N/A
3/31/20166,186-1,265N/A389N/A
12/31/20156,457-1,418N/A-114N/A
9/30/20156,704-509N/A-662N/A
6/30/20157,155-312N/A-554N/A
3/31/20156,930-166N/A-178N/A
12/31/20147,15335N/A207N/A
9/30/20147,10224N/A578N/A
6/30/20147,07432N/A781N/A
3/31/20147,18639N/A906N/A
12/31/20137,34051N/A738N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 000930 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.8%).

Earnings vs Market: 000930 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 000930 is expected to become profitable in the next 3 years.

Revenue vs Market: 000930's revenue (1.8% per year) is forecast to grow slower than the CN market (13.8% per year).

High Growth Revenue: 000930's revenue (1.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 000930's Return on Equity is forecast to be low in 3 years time (5.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y